CRBP Similar Chart Price Prediction
The price of CRBP is predicted to go up -40.59%, based on the high correlation periods with SNPX. The similarity of these two price pattern on the periods is 97.12%.
CRBP
SNPX
Down: -40.59%Similarity: 97.12%
CRBP Revenue Forecast
CRBP EPS Forecast
CRBP FAQs
What is CRBP eps forecast for next quarter？
CRBP Analyst's Forecast
Biren Amin
Piper Sandler
Buy
2024-12-02
Price Target
$35
Upside
+96.19%
Piper Sandler analyst Biren Amin initiated coverage of Corbus Pharmaceuticals with an Overweight rating and $35 price target. The company's Nectin-4 ADC, CRB-701, is differentiated from competitors due to its novel linker-payload technology which could allow for a better safety profile while driving encouraging efficacy in solid tumors such as cervical cancer and other solid tumors, the analyst tells investors in a research note. In addition, the firm thinks CRB-913 has good potential to be combined with incretins.
